148 related articles for article (PubMed ID: 76930)
1. Is measurement of placental function and maternal weight worth while?
Gordon YB; Lewis JD; Pendlebury DJ
Lancet; 1978 May; 1(8072):1001-3. PubMed ID: 76930
[TBL] [Abstract][Full Text] [Related]
2. Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein.
Grudzinskas JG; Gordon YB; Menabawey M; Lee JN; Wadsworth J; Chard T
Am J Obstet Gynecol; 1983 Sep; 147(1):10-2. PubMed ID: 6604456
[TBL] [Abstract][Full Text] [Related]
3. Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
Granat M; Sharf M; Diengott D; Spindel A; Kahana L; Elrad H
Am J Obstet Gynecol; 1977 Nov; 129(6):647-54. PubMed ID: 920766
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of human-placental-lactogen values in late pregnancy.
Letchworth AT; Slattery M; Dennis KJ
Lancet; 1978 May; 1(8071):955-7. PubMed ID: 76889
[TBL] [Abstract][Full Text] [Related]
5. [The surveillance of pregnancies with suspected placental dysfunktion. I. Material and methods (author's transl)].
Schmid J
Z Geburtshilfe Perinatol; 1975 Dec; 179(6):420-4. PubMed ID: 1241201
[TBL] [Abstract][Full Text] [Related]
6. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
Wolfrum R; Bordasch C; Holweg J
J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
[TBL] [Abstract][Full Text] [Related]
7. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
8. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
9. The relative significance of human placental lactogen in the diagnosis of retarded fetal growth.
Daikoku NH; Tyson JE; Graf C; Scott R; Smith B; Johnson JW; King TM
Am J Obstet Gynecol; 1979 Oct; 135(4):516-21. PubMed ID: 484651
[TBL] [Abstract][Full Text] [Related]
10. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
[TBL] [Abstract][Full Text] [Related]
11. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
[TBL] [Abstract][Full Text] [Related]
12. Prediction of small-for-gestational-age neonates: screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C; Gallo DM; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Sep; 46(3):341-9. PubMed ID: 25969963
[TBL] [Abstract][Full Text] [Related]
13. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
[TBL] [Abstract][Full Text] [Related]
14. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
15. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Tsiakkas A; Duvdevani N; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 May; 45(5):591-8. PubMed ID: 25653039
[TBL] [Abstract][Full Text] [Related]
16. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
[TBL] [Abstract][Full Text] [Related]
17. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
18. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of placental vascularization by three-dimensional ultrasound examination in second and third trimester of pregnancies complicated by chronic hypertension, gestational hypertension or pre-eclampsia.
Surányi A; Altorjay Á; Kaiser L; Nyári T; Németh G
Pregnancy Hypertens; 2017 Apr; 8():51-59. PubMed ID: 28501280
[TBL] [Abstract][Full Text] [Related]
20. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
Kullander S; Marsál K; Persson PH
Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
